Doctors at the Army Hospital (Research and Referral) have achieved a world first breakthrough in glaucoma surgery, ...

The risk for endophthalmitis after glaucoma drainage rises for up to 5 years and is much higher than that for a ...

The Hydrus Microstent is a tiny, 8mm flexible nitinol device, which is an implant or instrument made from a nickel-titanium alloy.

Glaucoma is likely to be treated when IOP reaches 22 mm Hg, but research shows that risk consistently increases even at lower IOP levels, according to a study published in JAMA Ophthalmology.“In ...

A population study of California Medicare patients found that high air pollution levels correlated with the risk for failure of incisional glaucoma surgery.

Please provide your email address to receive an email when new articles are posted on . Ptosis and strabismus occurred in 3.7% and 1.7% of patients, respectively, and 1% had both. Most patients in all ...

Glaukos has claimed a series of regulatory clearances in Europe for its micro-scale surgical implants to treat patients with glaucoma, expanding the company’s reach overseas. The green lights under ...

Ophthalmic research focus grows around glaucoma therapy and device development Webinar spotlight covers BL therapy and ELIOS surgical platform technology Sector discussion expands alongside activity ...

The Pediatric Eye Disease Investigator Group collected data on children who had lensectomy prior to age 13 years in a 5-year span. Cataract surgery led to glaucoma-related adverse events (AEs) in ...

In Bihar, awareness about glaucoma is gradually increasing, and many eye hospitals now provide advanced treatment solutions based on the stage and type of the disease.

Experts explain whether Lasik or lens implants affect your risk, and how a hair strand-like microshunt could reduce reliance on lifelong eye drops for patients.

Alcon introduces a minimally invasive glaucoma surgery device designed to lower intraocular pressure and reduce medication dependence during cataract surgery ...